First identified in human plasma in the 1970s, this small tripeptide glycyl-L-histidyl-L-lysine, bound to a copper ion has become one of the most extensively referenced compounds in dermal and wound-healing research literature, largely because its copper-binding structure gives it a distinct mechanism from most other peptide sciences on the market
Managing vitamin B12 deficiency means knowing about all the available products
When this barrier is compromised, undigested food particles, toxins, and bacterial byproducts can enter the bloodstream, contributing to inflammation and symptoms commonly associated with IBS, SIBO, and leaky gut
A dermatologist or physician typically evaluates each patients suitability before starting GHK-Cu
Loading phase The loading phase establishes the initial therapeutic concentration in the tissue